[Headlines Only] [Top Stories Only]
· Cessation
· Vaccines

New Drug Helps Smokers Quit and Stay Quit 

But experts say Chantix is no 'magic bullet'
Jump to full article: HealthDay [HealthScout], 2006-07-04
Author: E.J. Mundell HealthDay Reporter


The drug Chantix (varenicline) quadruples a smoker's odds of kicking the habit, and is twice as effective as another smoking-cessation drug, Zyban (bupropion), according to three studies published in the July 5 Journal of the American Medical Association.

Chantix, which won U.S. Food and Drug Administration approval May 11, also greatly decreases smokers' likelihood of relapse in the first six months after quitting, one of the studies found. . . .

But an editorial that accompanies the three JAMA studies warns that much of the hype around the new drug may be unwarranted, because Chantix remains a far-from-perfect means of quitting smoking.

Jump to full article »